Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High Flow Oxygen Therapy in Mild and Moderate Acute Hypoxic Respiratory Failure

NCT06336265 is registered in ClinicalTrials.gov with Xingui Dai as lead sponsor.

NCT NCT06336265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06336265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High Flow Oxygen Therapy in Mild and Moderate Acute Hypoxic Respiratory Failure
Lead sponsor
Xingui Dai
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2024
Completion date
December 31, 2024
Enrollment
269 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic respiratory failure